Drug profile · INN
amisulpride
BARHEMSYS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
amisulpride (BARHEMSYS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN amisulpride
Brand BARHEMSYS
Route INTRAVENOUS
Formulation SOLUTION
Frequently asked questions
What is amisulpride?
amisulpride (BARHEMSYS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for amisulpride?
BARHEMSYS is a marketed brand name for amisulpride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amisulpride?
amisulpride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.